Cite
HARVARD Citation
De Benedetti, F. et al. (n.d.). FRI0328 Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): 2-year data from tender, a phase 3 clinical trial. Annals of the rheumatic diseases. p. 425. [Online].